CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL（当前治疗研究-临床和实验杂志）影响因子_期刊投稿发表

期刊简介

We also encourage the submission of manuscripts presenting preclinical and very preliminary research that may stimulate further investigation of potentially relevant findings, as well as in-depth review articles on specific therapies or disease states, and applied health delivery or pharmacoeconomics.CTR encourages and supports the submission of manuscripts describing:• Interventions designed to understand or improve human health, disease treatment or disease prevention;• Studies that focus on problems that are uncommon in resource-rich countries;• Research that is "under-published" because of limited access to monetary resources such as English language support and Open Access fees (CTR offers deeply discounted English language editing);• Republication of articles previously published in non-English journals (eg, evidence-based guidelines) which could be useful if translated into English;• Preclinical and clinical product development studies that are not pursued for further investigation based upon early phase results.

我们还鼓励提交可能激发对潜在相关发现的进一步调查的临床前研究和非常初步的手稿，以及关于特定疗法或疾病状态的深入评论文章，以及应用健康交付或药物经济学。CTR鼓励并支持提交描述以下内容的手稿: 旨在了解或改善人类健康、疾病治疗或疾病预防的干预措施; 关注资源丰富国家不常见问题的研究；• 由于获得金钱资源 (例如英语支持和开放获取费用) 而 “出版不足” 的研究 (CTR提供的英语编辑折扣很大);• 重新出版以前在非英语期刊上发表的文章 (例如，循证指南)，如果翻译成英文，可能会很有用; • 临床前和临床产品开发研究，不进行基于早期结果的进一步研究。

《CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL》期刊已被查看：次

分区信息